CSPC Pharmaceutical Group Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 13,822.275 million compared to CNY 12,589.597 million a year ago. Net income was CNY 3,062.569 million compared to CNY 2,313.996 million a year ago. Basic earnings per share from continuing operations was CNY 0.2562 compared to CNY 0.1936 a year ago. Diluted earnings per share from continuing operations was CNY 0.2562 compared to CNY 0.1935 a year ago.